Steroid drug hailed as 'breakthrough' for seriously ill COVID-19 patients
Go back to Steroid drug hailed as 'breakthrough' for seriously ill COVID-19 patients| Gilead Sciences (NASDAQ: GILD) | Delayed: 144.48 -0.33 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.81 | 52 Week High | $108.63 | |||
| Open | $145.24 | 52 Week Low | $71.39 | |||
| Day High | $145.99 | P/E | 79.82 | |||
| Day Low | $144.48 | EPS | $1.81 | |||
| Volume | 371,101 | |||||

